- Investing Ideas
- /
- Canadian Pharmaceuticals & Biotech Potentially Undervalued Companies
Canadian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
49
Companies with a Value score of at least 3, ordered by Value score
49 companies
Green Thumb Industries
Market Cap: CA$2.4b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$11.21
7D
6.3%
1Y
-19.7%
Knight Therapeutics
Market Cap: CA$601.9m
Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.
GUD
CA$6.07
7D
-2.6%
1Y
2.9%
Rubicon Organics
Market Cap: CA$38.3m
Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.
ROMJ
CA$0.61
7D
8.9%
1Y
45.2%
MediPharm Labs
Market Cap: CA$29.5m
Operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally.
LABS
CA$0.07
7D
0%
1Y
0%
TerrAscend
Market Cap: CA$399.3m
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.
TSND
CA$1.19
7D
6.3%
1Y
-32.0%
Covalon Technologies
Market Cap: CA$59.8m
Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.
COV
CA$2.15
7D
-1.8%
1Y
-35.8%
Street Capital
Market Cap: CA$1.4m
Focuses on the production and sale of cannabis-based hashish and other cannabis products in Canada.
STRC.X
CA$0.005
7D
0%
1Y
0%
Eli Lilly
Market Cap: CA$670.6b
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.
LLY
CA$27.12
7D
-2.3%
1Y
-21.5%
Roche Holding
Market Cap: CA$223.1b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROG
CA$20.54
7D
-1.2%
1Y
n/a
Cannabist Company Holdings
Market Cap: CA$50.5m
The Cannabist Company Holdings Inc. cultivates, manufactures, and sells cannabis products and related services for the medical and adult-use markets in the United States and internationally.
CBST
CA$0.15
7D
-9.1%
1Y
-49.2%
HLS Therapeutics
Market Cap: CA$175.8m
A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders, central nervous system, and cardiovascular disease in Canada, the United States, and internationally.
HLS
CA$5.51
7D
-2.8%
1Y
57.4%
Christina Lake Cannabis
Market Cap: CA$9.9m
A license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada.
CLC
CA$0.04
7D
-11.1%
1Y
14.3%
Roche Holding
Market Cap: CA$223.1b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROCH
CA$9.91
7D
3.3%
1Y
n/a